Abstract
Endovascular abdominal aortic aneurysm repair (EVAR) is a safe and efficacious treatment for both unruptured and ruptured abdominal aortic aneurysms. While perioperative mortality is lower with EVAR, long-term outcomes are similar between EVAR and open repair, including quality of life and cost-effectiveness. We review the long-term outcomes from the EUROSTAR registry, and DREAM, EVAR 1, and OVER trials.
Original language | English |
---|---|
Pages (from-to) | 135-141 |
Number of pages | 7 |
Journal | Unknown Journal |
Volume | 9 |
State | Published - 2013 |
Externally published | Yes |